TuHURA Biosciences, Inc
Price
FilingsNewest: 8-K, New debt or obligationSep 24 →InsidersNo open-market buys or sales.→HoldersVanguard 3.6%Northern Trust 2.5%BlackRock 1.1%→Financing →PeersClosest companies: CALC, SRFM, ARTV→
From the filings
Figures
- Revenue
- $0.00last 12 months
- Net income
- −$31.6Mlast 12 months
- Operating cash flow
- −$27.3Mlast 12 months
- Cash and equivalents
- $995,977at the last balance sheet
- Total debt
- $3.6Mat the last balance sheet
- Shares outstanding
- 63.7M shareson issue